Quality control in the endoplasmic reticulum: Lessons from hereditary myeloperoxidase deficiency

Journal of Laboratory and Clinical Medicine

Volumn 134, Issue 3, 1999, Pages 215-221

  Nauseef, William M ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0033200131     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(99)90200-7     Document Type: Article

References (53)

1. 1. Borregaard N, Cowland JB. Granules of the human neutrophilic polymorphonuclear leukocyte. Blood 1997;89:3503-21.
2. 2. Hampton MB, Kettle AJ, Winterbourn CC. Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing. Blood 1998;92:3007-17.
3. 3. Babior BM, Kipnes RS, Curnutte JT. Biological defence mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent. J Clin Invest 1973;52:741-4.
4. 4. Babior BM. NADPH oxidase: an update. Blood 1999; 93:1464-76.
5. 5. Ramos CL, Pou S, Britigan BE, Cohen MS, Rosen GM. Spin trapping evidence for myeloperoxidase-dependent hydroxyl radical formation by human neutrophils and monocytes. J Biol Chem 1992;267:8307-12.
6. 2-chloride system. FEBS Lett 1999;443:154-8.
7. 7. Klebanoff SJ. Myeloperoxidase: occurrence and biological function. In: Everse J, Everse K, Grisham M, editors. Peroxidases in chemistry and biology. Boca Raton, FL: CRC Press; 1991. p. 1-36.
8. 8. Taurog A, Wall M. Proximal and distal histidines in thyroid peroxidase: relation to the alternatively spliced form, TPO-2. Thyroid 1999;8:185-91.
9. 9. Gullberg U, Andersson E, Garwicz D, Lindmark A, Olsson I. Biosynthesis, processing and sorting of neutrophil proteins: insight into neutrophil granule development. Eur J Haematol 1997;58:137-53.
10. 10. Olsson I, Persson A-M, Strömberg K. Biosynthesis, transport, and processing of myeloperoxidase in the human leukemia promyelocytic cell line HL-60 and normal marrow cells. Biochem J 1984;223:911-20.
11. 11. Kowalski JM, Parekh RN, Mao J, Wittrup KD. Protein folding stability can determine the efficiency of escape from endoplasmic reticulum quality control. J Biol Chem 1998;273:19453-8.
12. 12. Kopito RR. ER quality control: the cytoplasmic connection. Cell 1997;88:427-30.
13. 13. Tatu U, Helenius A. Interactions between newly synthesized glycoproteins, calnexin and a network of resident chaperones in the endoplasmic reticulum. J Cell Biol 1997;136:555-65.
14. 14. Helenius A, Trombetta ES, Hebert DN, Simons JF. Calnexin, calreticulin and the folding of glycoproteins. Trends Cell Biol 1997;7:193-200.
15. 15. Rodan AR, Simons JF, Trombetta ES, Helenius A. N-linked oligosaccharides are necessary and sufficient for association of glycosylated forms of bovine RNase with calnexin and calreticulin. EMBO J 1996;15:6921-30.
16. 16. Michalak M, Milner RE, Burns K, Opas M. Calreticulin. Biochem J 1992;285:681-92.
17. 17. Wada I, Imai S, Kai M, Sakane F, Kanoh H. Chaperone function of calreticulin when expressed in the endoplasmic reticulum as the membrane-anchored and soluble forms. J Biol Chem 1995;270:20298-304.
18. 18. Nauseef WM, McCormick SJ, Goedken M. Coordinated participation of calreticulin and calnexin in the biosynthesis of myeloperoxidase. J Biol Chem 1998;273:7107-11.
19. 19. Nauseef WM, McCormick SJ, Clark RA. Calreticulin functions as a molecular chaperone in the biosynthesis of myeloperoxidase. J Biol Chem 1995;270:4741-7.
20. 20. Akin DT, Kinkade JM Jr, Parmley RT. Biochemical and ultrastructural effects of monensin on the processing, intracellular transport, and packaging of myeloperoxidase into low and high density compartments of human leukemia (HL-60) cells. Arch Biochem Biophys 1987;257:451-63.
21. 21. Akin DT, Kinkade JM Jr. Processing of a newly identified intermediate of human myeloperoxidase in isolated granules occurs at neutral pH. J Biol Chem 1986;261:8370-5.
22. 22. Akin DT, Kinkade JM Jr. Evidence for the involvement of an acidic compartment in the processing of myeloperoxidase in human promyelocytic leukemia HL-60 cells. Arch Biochem Biophys 1987;255:428-36.
23. 23. Malech HL, Nauseef WM. Primary inherited defects in neutrophil function: etiology and treatment. Semin Hematol 1997;34:279-90.
24. 24. Kutter D, Al-Haidari K, Thoma J. Myeloperoxidase deficiency: simple methods for its diagnosis and significance of different forms. Klin Lab 1994;40:342-346.
25. 25. Lehrer RI, Cline MJ. Leukocyte myeloperoxidase deficiency and disseminated candidiasis: the role of myeloperoxidase in resistance to Candida infection. J Clin Invest 1969;48:1478-8.
26. 26. Aratani Y, Koyama H, Nyui S-I, Suzuki K, Kura F, Maeda N. Severe impairment in early host defense against Candida albicans in mice deficient in myeloperoxidase. Infect Immun 1999;67:1828-36.
27. 27. Petrides PE. Molecular genetics of peroxidase deficiency. J Mol Med 1998;76:688-98.
28. 28. Nauseef WM, Root RK, Malech HL. Biochemical and immunologic analysis of hereditary myeloperoxidase deficiency. J Clin Invest 1983;71:1297-307.
29. 29. Nauseef WM. Aberrant restriction endonuclease digests of DNA from subjects with hereditary myeloperoxidase deficiency. Blood 1989;73:290-5.
30. 30. Nauseef WM, Brigham S, Cogley M. Hereditary myeloperoxidase deficiency due to a missense mutation of arginine 569 to tryptophan. J Biol Chem 1994;269:1212-6.
31. 31. Nauseef WM, Cogley M, Bock S, Petrides PE. Pattern of inheritance in hereditary myeloperoxidase deficiency associated with the R569W missense mutation. J Leukoc Biol 1998;63:264-9.
32. 32. Romano M, Dri P, Dadalt L, Patriarca P, Baralle FE. Biochemical and molecular characterization of hereditary myeloperoxidase deficiency. Blood 1997;90:4126-34.
33. 33. Lozzio BB, Lozzio CB. Properties and usefulness of the original K-562 human myelogenous leukemia cell line. Leuk Res 1979;3:363-70.
34. 34. Nauseef WM, Cogley M, McCormick S. Effect of the R569W missense mutation on the biosynthesis of myeloperoxidase. J Biol Chem 1996;271:9546-9.
35. 35. Davey CA, Fenna RE. 2.3 Å resolution X-ray crystal structure of the bisubstrate analogue inhibitor salicylhydroxamic acid bound to human myeloperoxidase: a model for a prereaction complex with hydrogen peroxide. Biochemistry 1996;35:10967-73.
36. 36. Zeng J, Fenna RE. X-ray crystal structure of canine myeloperoxidase at 3 Å resolution. J Mol Biol 1992; 226:185-207.
37. 37. Hartl FU, Hlodan R, Langer T. Molecular chaperones in protein folding: the art of avoiding sticky situations. Trends Biochem Sci 1994;19:20-5.
38. 38. Hartl FU, Martin J. Molecular chaperones in cellular protein folding. Curr Opin Struct Biol 1995;5:92-102.
39. 39. Kuznetsov G, Nigam SK. Folding of secretory and membrane proteins. N Engl J Med 1998;339:1688-95.
40. 40. Pind S, Riordan JR, Williams DB. Participation of the endoplasmic reticulum chaperone calnexin (p88, IP90) in the biogenesis of the cystic fibrosis transmembrane conductance regulator. J Biol Chem 1994;269:12784-8.
41. 41. Denning GM, Anderson MP, Amara JF, Marshall J, Smith AE, Welsh MJ. Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. Nature 1992;358:761-4.
42. 42. Hwang C, Sinskey AJ, Lodish HF. Oxidized redox state of glutathione in the endoplasmic reticulum. Science 1992;257:1496-502.
43. 43. Lodish HF, Kong N. The secretory pathway is normal in dithiothreitol-treated cells, but disulfide-bonded proteins are reduced and reversibly retained in the endoplasmic reticulum. J Biol Chem 1993;268:20598-605.
44. 44. DeLeo FR, Goedken M, McCormick SJ, Nauseef WM. A novel form of hereditary myeloperoxidase deficiency linked to endoplasmic reticulum/proteasome degradation. J Clin Invest 1998;101:2900-9.
45. 45. Brodsky JL, McCracken AA. ER-associated and proteasome-mediated protein degradation: how two topologically restricted events came together. Trends Cell Biol 1997;7:151-6.
46. 46. Jensen TJ, Loo MA, Pind S, Williams DB, Goldberg AL, Riordan JR. Multiple proteolytic systems, including the proteasome, contribute to CFTR processing. Cell 1995;83: 129-35.
47. 47. Fenteany G, Schreiber SL. Lactacystin, proteasome function, and cell fate. J Biol Chem 1998;273:8545-8.
48. 1-antitrypsin Z, in the endoplasmic reticulum requires proteasome activity. J Biol Chem 1996;271:22791-5.
49. 49. Ou WJ, Thomas DY, Bell AW, Bergeron JJM. Casein kinase II phosphorylation of signal sequence receptor α and the associated membrane chaperone calnexin. J Biol Chem 1992;267:23789-96.
50. 50. Wong HN, Ward MA, Alexander W, Chevet E, Bains S, Blackstock WP, et al. Conserved in vivo phosphorylation of calnexin in casein kinase II sites as well as a protein kinase C/proline-directed kinase site. J Biol Chem 1998;273:17227-35.
51. 51. Capps GG, Zuniga MC. Class I histocompatibility molecule association with phosphorylated calnexin. Implications for rates of intracellular transport. J Biol Chem 1994;269:11634-9.
52. 52. Nauseef WM, McCormick S, Yi H. Roles of heme insertion and the mannose-6-phosphate receptor in processing of the human myeloid lysosomal enzyme, myeloperoxidase. Blood 1992;80:2622-33.
53. 53. Bening U, Castino R, Harth N, Isidoro C, Hasilik A. Lysosomal segregation of a mannose-rich glycoprotein imparted by the prosequence of myeloperoxidase. J Cell Biochem 1998;71:158-68.